Kedrion Biopharma, Inc.

NJ · United States · Reporting entity ID 100000086365

Total reported 2019–2025

$759K

#1,416 of 2,960 reporting companies — 0% of all reported industry payments

$327K in general payments across 1,949 records, plus $431K in research funding across 99 records.

How it breaks down

General payments $327,496

Research funding $431,184

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.